Sanjay Subramanian
CIK 1790246 · SVP, CFO & Head of BD · last filed 2025-07-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$195.0K
Companies
2
Total Filings
26
Lifetime Open-Market Net
-$1.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Inozyme Pharma, Inc. (INZY) Delisted | SVP, CFO & Head of BD | 39,701 | $4.00 | $158.8K | $100.0K | 9 | 2025-06-27 |
| OCGN | Chief Financial Officer | 161,125 | $1.21 | $195.0K | -$1.16M | 16 | 2022-01-05 |
Recent Filings · Page 3 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-01 | OCGN | Exer (M) | +35,591 | $18.2K | EDGAR |
| 2021-01-04 | OCGN | Grant (A) | — | $0 | EDGAR |
| 2020-05-07 | OCGN | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | OCGN | Grant (A) | — | $0 | EDGAR |
| 2019-11-26 | OCGN | Buy (P) | +5,000 | $1.4K | EDGAR |
| 2019-10-04 | OCGN | Mixed | +5,000 | $9.4K | EDGAR |
Showing 21–26 of 26
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.